drugset / Trial / NCT02456025
Topical Tacrolimus in Vernal Keratoconjunctivitis
RandomizedParallel-groupDouble-blindTreatment
Summary
The main aim of this study is to evaluate the efficacy and safety of topical tacrolimus 0.01% eyedrops in patients with vernal keratoconjunctivitis.
Timeline
- Start
- 2013-04
- Primary completion
- 2016-12
- Completion
- 2016-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Tacrolimus | Small molecule | 0.01 % | Topical |